JW Pharmaceutical Corporation (KRX:001065)

JW Pharmaceutical Revenue

JW Pharmaceutical had revenue of 200.02B KRW in the quarter ending September 30, 2025, with 11.96% growth. This brings the company's revenue in the last twelve months to 764.21B, up 3.76% year-over-year. In the year 2024, JW Pharmaceutical had annual revenue of 719.38B, down -3.89%.

• Revenue (ttm): 764.21B
• Revenue Growth: +3.76%
• P/S Ratio: 0.79
• Revenue / Employee: 715.55M
• Employees: 1,068
• Market Cap: 600.19B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	719.38B	-29.15B	-3.89%
Dec 31, 2023	748.53B	64.18B	9.38%
Dec 31, 2022	684.35B	77.77B	12.82%
Dec 31, 2021	606.58B	59.25B	10.83%
Dec 31, 2020	547.34B	36.00B	7.04%